![Theresa Devins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Theresa Devins is Vice President-Clinical Operations at Cognition Therapeutics, Inc. since 2024.
Formerly, Dr. Devins was Director-Clinical Operations at Eisai, Inc.
Theresa Devins active positions
| Companies | Position | Start |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
Former positions of Theresa Devins
| Companies | Position | End |
|---|---|---|
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
- Stock Market
- Insiders
- Theresa Devins
Choose MarketScreener 
